Skip to main content

Sylvamo Corp

For the period ended Mar 31, 2025. Filed May 9, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 9, 2025

SLVM$38.18+0.5%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Balance Sheets - March , 202 and December 31,

CONDENSED CONSOLIDATED BALANCE SHEETS

March 31, 2025December 31, 2024
(unaudited)
ASSETS
Current Assets
Cash and temporary investments$154$205
Accounts and notes receivable, net416429
Contract assets2626
Inventories372361
Other current assets4342
Total Current Assets1,0111,063
Plants, Properties and Equipment, net977944
Forestlands350319
Goodwill119111
Right of Use Assets5958
Deferred Charges and Other Assets113109
TOTAL ASSETS$2,629$2,604
LIABILITIES AND EQUITY
Current Liabilities
Accounts payable$386$375
Notes payable and current maturities of long-term debt2322
Accrued payroll and benefits5279
Other current liabilities155206
Total Current Liabilities616682
Long-Term Debt794782
Deferred Income Taxes162152
Other Liabilities149141
Commitments and Contingent Liabilities (Note 11)
Equity
Common stock $1 par value, 200.0 shares authorized, 45.5 shares and 44.9 shares issued and 40.7 shares and 40.6 shares outstanding at March 31, 2025 and December 31, 2024, respectively4545
Paid-in capital7871
Retained earnings2,4632,455
Accumulated other comprehensive loss(1,410)(1,490)
1,1761,081
Less: Common stock held in treasury, at cost, 4.8 shares and 4.3 shares at March 31, 2025 and December 31, 2024, respectively(268)(234)
Total Equity908847
TOTAL LIABILITIES AND EQUITY$2,629$2,604
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.